Polar Bomb
A cold-weather-branded hybrid whose lineage and effects are largely undocumented outside marketing copy and forum reports.
Polar Bomb is a minor-market strain name with almost no verifiable paper trail. There's no peer-reviewed chemistry, no breeder registry entry I can confirm, and no clinical work on it — anything you read about 'guaranteed' effects or precise THC numbers is marketing or crowd-sourced guesswork. If you're buying it, treat the label as branding and judge the actual jar in front of you by its lab COA, smell, and your own tolerance.
Overview
Polar Bomb is a cannabis strain name that circulates on dispensary menus and seed reseller sites, usually pitched as a potent hybrid with a cold, minty, or gassy nose. Beyond that, the trail goes cold fast. There is no peer-reviewed chemotype analysis of Polar Bomb, no listing in cannabis genetic databases with verifiable breeder provenance that I can confirm, and no government or lab dataset that singles it out No data.
When a strain name has this little documentation, what's actually in the jar varies enormously between growers. Two products sold as 'Polar Bomb' from different sources are effectively different cultivars unless clonally linked — a well-documented problem across the cannabis market [1][2].
Chemistry
There is no published cannabinoid or terpene profile for Polar Bomb from a peer-reviewed source or a regulator dataset No data. Retailer menus sometimes list THC values in the 20–25% range, but menu numbers in legal markets have documented accuracy problems — several studies have shown label THC frequently overstates lab-measured THC, and inter-lab variation is significant [3][4].
If you want to know the chemistry of a specific Polar Bomb sample, the only reliable answer is the Certificate of Analysis (COA) for that batch. Broader research shows that chemovar (the actual cannabinoid + terpene fingerprint) predicts effects far better than the strain name on the label [1][5].
Reported effects
No clinical trial has studied Polar Bomb specifically, and none is likely to — strain-level clinical research essentially does not exist for boutique hybrids No data. User reports on forums and menu descriptions typically describe a heavy, relaxing high with some cerebral onset, but this is Anecdote and heavily shaped by expectancy: people who are told a strain is 'strong indica' tend to report sedation regardless of actual chemistry [6].
The honest framing: effects from any given Polar Bomb purchase will depend on that batch's THC, minor cannabinoids, terpene mix, your tolerance, dose, and setting — not on the name.
Lineage
Reported parentage for Polar Bomb varies across seed banks and menu blurbs, and I cannot verify any specific cross from a primary breeder source Disputed. Rather than repeat a lineage claim I can't source, I'll note the general problem: cannabis strain lineage is frequently unreliable. Genetic studies have shown that samples sold under the same strain name are often not closely related, and that reported pedigrees often don't match genotype data [1][2].
If lineage matters to you (for allergy avoidance, chemotype prediction, or breeding), demand documentation from the specific seller — and understand that even then, without genotyping, it's a claim, not a proof.
Cultivation basics
I have no verifiable breeder-published grow data for Polar Bomb — flowering time, stretch, yield, and pest resistance are undocumented in any source I can point to No data. Retailer copy sometimes lists an 8–9 week flowering window, but this appears to be generic hybrid boilerplate rather than measured data.
General cannabis cultivation guidance applies: photoperiod hybrids typically flower 7–10 weeks indoors under 12/12, prefer VPD around 1.0–1.2 kPa in flower, and yield depends far more on training, light intensity (DLI), and environment than on the cultivar name [7]. If you're growing an unknown cut labeled Polar Bomb, treat the first run as a pheno-hunt: log flowering time, structure, and finish weight yourself.
Marketing vs. reality
The word 'Bomb' shows up on a lot of cannabis product names because it signals potency. Polar adds a cold, minty, or 'icy' aesthetic. Together, they suggest a specific experience — high THC, cooling terpenes, knockout effect — none of which is guaranteed by the name.
A few things worth pushing back on if you see them in menu copy:
- 'Indica-dominant' predicting sedation. The indica/sativa split has been repeatedly shown to be a poor predictor of chemistry or effects [1][8]. It's Disputed at best and folklore in most contexts.
- Precise THC percentages on the shelf tag. Independent testing has repeatedly found label THC inflated relative to third-party assays [3][4].
- 'Dominant terpene: myrcene → couchlock' style claims. The often-cited 0.5% myrcene 'threshold' for sedation has no controlled-trial basis; it's Anecdote popularized by industry blogs [5].
Bottom line: Polar Bomb is a name. Judge the flower, not the label.
Sources
- Peer-reviewed Schwabe AL, McGlaughlin ME. Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 2019, 1:3.
- Peer-reviewed Sawler J, Stout JM, Gardner KM, et al. The genetic structure of marijuana and hemp. PLoS ONE, 2015, 10(8):e0133292.
- Peer-reviewed Jikomes N, Zoorob M. The cannabinoid content of legal cannabis in Washington State varies systematically across testing facilities and popular consumer products. Scientific Reports, 2018, 8:4519.
- Peer-reviewed Schwabe AL, Johnson V, Harrelson J, McGlaughlin ME. Uncomfortably high: Testing reveals inflated THC potency on retail Cannabis labels. PLoS ONE, 2023, 18(4):e0282396.
- Peer-reviewed Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 2011, 163(7):1344-1364.
- Peer-reviewed Gilman JM, Schmitt WA, Potter K, et al. Identification of Δ9-tetrahydrocannabinol (THC) impairment using functional brain imaging. Neuropsychopharmacology, 2022, 47:944-952.
- Book Cervantes J. The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing, 2015.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLoS ONE, 2022, 17(5):e0267498.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...